Non-lethal weapons company Byrna (NASDAQ: BYRN) will be reporting earnings this Thursday before the bell. Here’s what you need to know.

Byrna beat analysts’ revenue expectations last quarter, reporting revenues of $35.25 million, up 26% year on year. It was a strong quarter for the company, with a beat of analysts’ EPS estimates and a narrow beat of analysts’ revenue estimates.

Is Byrna a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Byrna’s revenue to grow 13.6% year on year, slowing from the 57.3% increase it recorded in the same quarter last year.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Byrna has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at Byrna’s peers in the aerospace and defense segment, only AAR has reported results so far. It exceeded analysts’ revenue estimates, delivering year-on-year sales growth of 24.6%. The stock traded up 9.9% on the results.

Investors in the aerospace and defense segment have had steady hands going into earnings, with share prices flat over the last month. Byrna is down 12.7% during the same time and is heading into earnings with an average analyst price target of $29 (compared to the current share price of $9.43).

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.